PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
47.89
+1.96 (4.27%)
May 27, 2025, 3:57 PM - Market open
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $3.80 billion as of May 27, 2025. Its market cap has increased by 58.93% in one year.
Market Cap
3.80B
Enterprise Value
4.31B
1-Year Change
58.93%
Ranking
Category
Stock Price
$47.89
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $3.80B, an increase of 936.49%. That is a compound annual growth rate of 21.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 23, 2025 | 3.64B | 4.56% |
Dec 31, 2024 | 3.48B | 67.39% |
Dec 29, 2023 | 2.08B | -24.20% |
Dec 30, 2022 | 2.74B | -2.56% |
Dec 31, 2021 | 2.82B | -32.38% |
Dec 31, 2020 | 4.16B | 40.68% |
Dec 31, 2019 | 2.96B | 70.95% |
Dec 31, 2018 | 1.73B | 150.23% |
Dec 29, 2017 | 692.00M | 84.83% |
Dec 30, 2016 | 374.40M | -66.28% |
Dec 31, 2015 | 1.11B | -36.17% |
Dec 31, 2014 | 1.74B | 311.45% |
Dec 31, 2013 | 422.80M | 15.46% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 640.72B |
Johnson & Johnson | 367.98B |
AbbVie | 323.71B |
Novo Nordisk | 311.77B |
UnitedHealth Group | 268.12B |
Abbott Laboratories | 228.44B |
Novartis AG | 224.07B |
AstraZeneca | 219.48B |